Hooper Holmes Announces Third Quarter 2016 Financial Results

OLATHE, Kan., Nov. 10, 2016 (GLOBE NEWSWIRE) -- Hooper Holmes, Inc. (NYSE MKT:HH) today announced financial results for the quarter ended September 30, 2016.

Consolidated revenues totaled $9.75 million for the third quarter of 2016, an increase of 5.2% compared to the third quarter of 2015. The Company recorded a net loss of $2.1 million for the third quarter of 2016, which represents an improvement of 3.1% versus the third quarter of 2015. Adjusted EBITDA for the third quarter 2016 was a loss of $81,000, a significant improvement compared to the third quarter 2015. 

Gross profit for the 2016 third quarter increased to $2.5 million, a 15.9% improvement compared to the same period in 2015. Selling, general and administrative expenses for the three month period ended September 30, 2016, totaled $3.6 million, a decrease of 4.1% compared to the third quarter of 2015. 

Henry Dubois, President and CEO of Hooper Holmes commented, "Gross profit and adjusted EBITDA improved for the third consecutive quarter.  While we have experienced a longer than usual lead time in ramping up revenue from new contracts, revenues have increased 8.9% on a year-to-date basis, compared to 2015. As top line revenue increases, along with better gross and operating margins, we expect to be generating cash flows from operations."

Mr. Dubois continued, "Revenue from our top 10 Channel Partners and Clinical Research customers grew 25% in the 2016 third quarter compared to the 2015 third quarter, and 18% year-to-date on a year-over-year basis. Revenue from our top 10 Direct customers grew 17% compared to the 2015 third quarter. As a result of these trends our business in the fourth quarter 2016 is off to a good start and should compare favorably to the fourth quarter 2015. We believe this gives us a solid base on which to grow as we continue to execute our plans to improve financial performance. As 2017 begins we expect to see continued year-over-year improvements."

Conference Call

The Company will host a conference call today, Thursday, November 10, 2016, at 7:30 a.m. CT (8:30 a.m. ET) to discuss its third quarter 2016 financial results. A slide presentation will accompany the conference call and is available on the Company's website located at www.hooperholmes.com.

To participate in the conference call, please dial 888-438-5493 or internationally 1-719-457-2651, conference ID: 5250866, five to ten minutes before the call is scheduled to begin. A live webcast will be hosted on the Company's website located at www.hooperholmes.com. A replay of the conference call will be available through November 17, 2016, by dialing 844-512-2921, or internationally 1-412-317-6671.  The access code for the replay is 5250866. 

About Hooper Holmes

Hooper Holmes mobilizes a national network of health professionals to provide on-site health screenings, laboratory testing, risk assessment and sample collection services to wellness and disease management companies, employers and brokers, government organizations and academic institutions nationwide. Under the Accountable Health Solutions brand, the Company combines smart technology, healthcare and behavior change expertise to offer comprehensive health and wellness programs that improve health, increase efficiencies and reduce healthcare delivery costs.

More information is available at hooperholmes.com and at accountablehealthsolutions.com.

This press release contains forward-looking statements within the meaning of the federal securities laws. Forward-looking statements may generally be identified by the use of words such as "anticipate," "believe," "expect," "intends," "plan," and "will" or, in each case, their negative, and other variations or comparable terminology.  These forward-looking statements include all statements other than historical facts.   Any forward-looking statement made by management during this call is not a guarantee of future performance, and actual results may differ materially from those expressed in or suggested by the forward-looking statements, as a result of various factors, including, without limitation the factors discussed in the "Risk Factors" section of the company's Annual Report on Form 10-K for the year ended December 31, 2015, as the same may be updated from time-to-time in subsequent filings with the Securities and Exchange Commission. Any forward-looking statement made by management on this call speaks only as of the date hereof, and the Company has no obligation, and does not intend, to update any forward-looking statements after the date hereof, except as required by federal securities laws. In addition, management uses the non-GAAP performance measures EBITDA and Adjusted EBITDA on this call.  You can find a reconciliation of such measures to their nearest GAAP equivalent in the Company's earnings release, which is available on our website.
Hooper Holmes, Inc.          
Consolidated Balance Sheets          
(in thousands)            
                 
            September 30, 2016   December 31, 2015
ASSETS       (unaudited)    
Current assets:            
  Cash and cash equivalents       $ 825     $ 2,035  
  Accounts receivable, net of allowance for doubtful accounts         7,403       5,565  
  Inventories         1,481       567  
  Other current assets       431       331  
    Total current assets       10,140       8,498  
                 
Property, plant and equipment, net       1,939       2,771  
Intangible assets, net         4,356       5,331  
Goodwill         633       633  
Other assets         394       450  
    Total assets         17,462       17,683  
                 
LIABILITIES AND STOCKHOLDERS' (DEFICIT) EQUITY        
Current liabilities:            
  Accounts payable         5,555       5,339  
  Accrued expenses         2,526       2,313  
  Short-term debt         6,924       5,330  
  Other current liabilities       2,591       2,873  
  Total current liabilities       17,596       15,855  
                 
Other long term liabilities       444       1,611  
                 
Commitments and contingencies          
                 
Stockholders' (deficit) equity:          
  Common stock         402       3,121  
  Additional paid-in capital       165,988       156,195  
  Accumulated deficit       (166,968 )     (159,028 )
              (578 )     288  
  Less: Treasury stock at cost       -       (71 )
  Total stockholders' (deficit) equity       (578 )     217  
    Total liabilities and stockholders' (deficit) equity   $ 17,462     $ 17,683  
                 

HOOPER HOLMES INC.                  
CONSOLIDATED STATEMENTS OF OPERATIONS                  
(unaudited; in thousands, except share and per share data)                  
                     
                     
                     
      Three months ended September 30,   Nine months ended September 30,  
        2016       2015       2016       2015    
                     
Revenues   $ 9,750     $ 9,272     $ 24,634     $ 22,615    
Cost of operations     7,282       7,143       18,941       18,060    
  Gross profit     2,468       2,129       5,693       4,555    
Selling, general and administrative expenses     3,586       3,740       11,138       10,212    
Transaction costs     50       57       379       737    
  Operating loss from continuing operations     (1,168 )     (1,668 )     (5,824 )     (6,394 )  
Interest expense, net     878       388       2,678       1,097    
Other income     (0 )     -       (887 )     -    
  Loss from continuing operations before taxes     (2,046 )     (2,056 )     (7,615 )     (7,491 )  
Income tax expense     5       5       15       15    
  Loss from continuing operations     (2,051 )     (2,061 )     (7,630 )     (7,506 )  
                     
Discontinued operations:                  
  Loss from discontinued operations     (1 )     (57 )     (310 )     (82 )  
Net loss   $ (2,052 )   $ (2,118 )   $ (7,940 )   $ (7,588 )  
                     
Reconciliation of GAAP results to Non-GAAP results                  
  Interest expense   $ 243     $ 208     $ 681     $ 366    
  Other debt related costs included in interest expense     635       180       1,997       731    
  Income tax expense     5       5       15       15    
  Depreciation and amortization     682       672       2,090       1,546    
  Share-based compensation expense     78       167       548       360    
  Severance costs     277       -       277       -    
  Stock payments in connection with debt amendments     -       -       50       -    
  Transaction costs     50       57       379       737    
  Transition costs     1       247       57       505    
  Portamedic contingent liability     -       168       150       168    
  Write-off of SWK Warrant #2     -       -       (887 )     -    
Adjusted (Non-GAAP) EBITDA   $ (81 )   $ (414 )   $ (2,583 )   $ (3,160 )  
                     
Adjusted EBITDA for third quarter 2016 was ($0.1 million), compared to ($0.4 million) in the third quarter of 2015. The above schedule is a description of adjustments made to net loss.  
                                     
                     
Income (loss) per share                  
  Continuing operations:                  
  Basic   $ (0.22 )   $ (0.40 )   $ (0.89 )   $ (1.49 )  
  Diluted     (0.22 )     (0.40 )     (0.89 )     (1.49 )  
  Discontinued operations:                  
  Basic     (0.00 )     (0.01 )     (0.04 )     (0.02 )  
  Diluted     (0.00 )     (0.01 )     (0.04 )     (0.02 )  
  Net loss:                  
  Basic     (0.22 )     (0.41 )     (0.93 )     (1.51 )  
  Diluted     (0.22 )     (0.41 )     (0.93 )     (1.51 )  
                     
Weighted average number of shares:                  
  Basic and diluted     9,149,418       5,185,986       8,604,846       5,026,095    
                     

For further information:Hooper HolmesHenry E. DuboisPresident and CEO(913) 764-1045Investors: Andrew BergerS.M. Berger & Company(216) 464-6400

Primary Logo